FDA warns Canadian company for selling unapproved, misbranded drugs

As bipartisan support in Congress for importation grows, FDA warns that a Canadian company is selling unapproved and misbranded drugs to U.S. consumers.

FDA accused CanaRx

Read the full 255 word article

User Sign In